473987-06-3 Usage
Uses
Used in Pharmaceutical Research and Development:
Ethyl 3-(piperidin-4-yl)propanoate hydrochloride is used as a research compound for its potential as a central nervous system depressant and analgesic. It is being studied for its potential use in the treatment of pain and neurological disorders.
Used in Pharmaceutical Synthesis:
Ethyl 3-(piperidin-4-yl)propanoate hydrochloride is used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique chemical structure allows it to be a valuable building block in the development of new drugs and therapeutic agents.
Safety Considerations:
It is important to handle ethyl 3-(piperidin-4-yl)propanoate hydrochloride with care and in accordance with safety guidelines due to its potential for neurological and physiological effects. Proper handling and storage are essential to minimize risks associated with its use in research and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 473987-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,9,8 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 473987-06:
(8*4)+(7*7)+(6*3)+(5*9)+(4*8)+(3*7)+(2*0)+(1*6)=203
203 % 10 = 3
So 473987-06-3 is a valid CAS Registry Number.
InChI:InChI=1S/C10H19NO2.ClH/c1-2-13-10(12)4-3-9-5-7-11-8-6-9;/h9,11H,2-8H2,1H3;1H
473987-06-3Relevant academic research and scientific papers
Design, synthesis, and structure-activity relationships of potent GPIIb/IIIa antagonists: Discovery of FK419
Yamanaka, Toshio,Ohkubo, Mitsuru,Kuroda, Satoru,Nakamura, Hideko,Takahashi, Fumie,Aoki, Toshiaki,Mihara, Kayoko,Seki, Jiro,Kato, Masayuki
, p. 4343 - 4352 (2007/10/03)
The discovery of the non-peptide antiplatelet injectable agent FK419 is reported. Based on the β-turn structure of RGD peptide sequences in the α chain of fibrinogen, which binds the glycoprotein IIb/IIIa (GPIIb/IIIa) on the surface of platelets to induce
BENZOFURAN DERIVATIVE
-
Page 183, (2008/06/13)
The present invention provides a benzofuran derivative of the formula [1]: wherein x is a group of the formula: -N="or" -CH=; Y is an optionally substituted amino group, an optionally substituted cycloalkyl group or an optionally substituted saturated heterocyclic group; A is a single bond, a carbon chain optionally having a double bond within or at the end(s) of the chain, or an oxygen atom; R1 is a hydrogen atom or a halogen atom; Ring B is an optionally substituted benzene ring; and R3 is a hydrogen atom, or a pharmaceutically acceptable salt thereof, which is useful as a medicament, especially as an activated blood coagulation factor X inhibitor.
